SCHEDULE 13D/A: Vida Ventures Updates Stake in Tectonic Therapeutic Following Share Dilution

Vida Ventures II, LLC and its affiliates have filed an amended Schedule 13D, reporting a decrease in their aggregate beneficial ownership of Tectonic Therapeutic, Inc. to 5.6% due to dilution from the Issuer's recent private placement.

Summary

• Vida Ventures II, LLC, Vida Ventures II-A, LLC, and VV Manager II, LLC (collectively, the "Reporting Persons") filed an Amendment No. 1 to their Schedule 13D regarding their beneficial ownership of Tectonic Therapeutic, Inc. Common Stock.
• The amendment was filed to update the aggregate percentage of Common Stock owned by the Reporting Persons, which decreased by over one percent since the original filing on June 27, 2024.
• This decrease in percentage ownership is attributed to dilution caused by Tectonic Therapeutic, Inc.'s sale of an additional 3,689,465 shares of Common Stock in a private placement.
• As of February 5, 2025, the Reporting Persons collectively beneficially own 1,028,674 shares of Tectonic Therapeutic, Inc. Common Stock.
• This aggregate ownership represents 5.6% of the Issuer's outstanding Common Stock, calculated based on 18,442,154 total shares outstanding (14,752,689 shares as of November 1, 2024, plus 3,689,465 shares from the private placement).
• The Reporting Persons acquired these securities for investment purposes, aiming to increase the value of their investments and the Issuer.
• They reserve the right to purchase or dispose of additional securities of the Issuer in the future, depending on market conditions and the Issuer's prospects.

Sentiment

Score: 5

Explanation: The document reports a decrease in the reporting person's percentage ownership due to dilution, which is a slight negative for their relative stake. However, the underlying reason is a capital raise by the Issuer, which is generally positive for the company's financial health. The reporting persons also reiterate their investment intent and flexibility, making the overall sentiment neutral.

Positives

• The Reporting Persons' stated purpose is for investment, aiming to increase the value of their investments and the Issuer, indicating continued belief in the company's potential.
• The company successfully completed a private placement, raising capital by selling 3,689,465 shares, which can strengthen its financial position.

Negatives

• The Reporting Persons' aggregate beneficial ownership percentage decreased by over one percent due to dilution from the Issuer's sale of additional shares.

Risks

• The Reporting Persons reserve the right to dispose of all or a portion of their securities at any time, which could lead to downward pressure on the stock price if a large block is sold.
• The Reporting Persons reserve the right to propose or participate in future transactions, including extraordinary corporate transactions such as mergers, reorganizations, liquidations, or sales of material assets, which could significantly alter the company's structure or operations.
• The Reporting Persons may change their investment intent at any time, which introduces uncertainty regarding their future actions concerning their stake in the Issuer.

Future Outlook

The Reporting Persons explicitly state their reservation of the right to increase or decrease their holdings of Tectonic Therapeutic, Inc. securities at any time, through open market or private transactions, including through Rule 10b5-1 programs. They also reserve the right to change their investment intent and to propose or participate in future extraordinary corporate transactions such as mergers, reorganizations, or liquidations.

Management Comments

• "The Reporting Persons purchased the aforementioned securities for investment purposes with the aim of increasing the value of their investments and the Issuer."
• "Subject to applicable legal requirements, one or more of the Reporting Persons may purchase additional securities of the Issuer from time to time in open market or private transactions, depending on its evaluation of the Issuer's business, prospects and financial condition, the market for the Issuer's securities, other developments concerning the Issuer, the reaction of the Issuer to the Reporting Persons' ownership of the Issuer's securities, other opportunities available to the Reporting Persons, and general economic, money market and stock market conditions."
• "Each of the Reporting Persons reserve the right to increase or decrease its holdings on such terms and at such times as each may decide."
• "Each of the Reporting Persons reserves the right to propose or participate in future transactions which may result in one or more of such actions, including but not limited to, an extraordinary corporate transaction, such as a merger, reorganization or liquidation, sale of a material amount of assets of the Issuer or its subsidiaries, or other transactions which might have the effect of causing the Common Stock to become eligible for termination of registration under Section 12(g) of the Act."

Industry Context

This filing is specific to a change in beneficial ownership for a particular company and does not directly provide information about broader industry trends. It reflects a common occurrence where venture capital firms adjust their reported stakes in portfolio companies, often due to subsequent capital raises by the portfolio company.

Stakeholder Impact

• Shareholders: Existing shareholders, including the Reporting Persons, experienced dilution of their percentage ownership due to the private placement. The capital raise itself could be beneficial for the company's operations and future value. The potential for future sales by the Reporting Persons could impact share price.
• Company (Tectonic Therapeutic, Inc.): The private placement provided additional capital, which can support its operations and strategic initiatives.

Next Steps

• The Reporting Persons may purchase additional securities of the Issuer from time to time.
• The Reporting Persons may dispose of all or a portion of their securities of the Issuer at any time.
• The Reporting Persons may propose or participate in future extraordinary corporate transactions involving the Issuer.

Key Dates

Keywords

Tectonic Therapeutic, Vida Ventures, Schedule 13D, SEC filing, beneficial ownership, private placement, dilution, common stock, investment, venture capital